NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Deadline: January 6, 2028
Opportunity Number: PAR-25-188
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: January 6, 2028
Status: Posted
CFDA Numbers: 93.121
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)
Deadline: November 12, 2027
Opportunity Number: PAR-25-216
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 12, 2027
Status: Posted
CFDA Numbers: 93.853
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)
Deadline: November 12, 2027
Opportunity Number: PAR-25-215
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 12, 2027
Status: Posted
CFDA Numbers: 93.853
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
Deadline: November 16, 2027
Opportunity Number: PAR-25-266
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 16, 2027
Status: Posted
CFDA Numbers: 93.865
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
Deadline: November 13, 2026
Opportunity Number: PAR-25-269
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 13, 2026
Status: Posted
CFDA Numbers: 93.213
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
Deadline: November 13, 2026
Opportunity Number: PAR-25-270
Agency: National Institutes of Health
Open Date: December 2, 2024
Close Date: November 13, 2026
Status: Posted
CFDA Numbers: 93.213
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-183
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-285
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-177
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-181
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-178
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-179
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-182
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-180
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
Deadline: October 15, 2027
Opportunity Number: PAR-25-184
Agency: National Institutes of Health
Open Date: November 26, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.242
New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
Deadline: May 7, 2027
Opportunity Number: PAR-25-272
Agency: National Institutes of Health
Open Date: November 25, 2024
Close Date: May 7, 2027
Status: Posted
CFDA Numbers: 93.866, 93.396, 93.865
Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R34 Clinical Trial Required)
Deadline: January 7, 2028
Opportunity Number: PAR-25-288
Agency: National Institutes of Health
Open Date: November 25, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
Deadline: January 7, 2027
Opportunity Number: PAR-25-159
Agency: National Institutes of Health
Open Date: November 25, 2024
Close Date: January 7, 2027
Status: Posted
CFDA Numbers: 93.273
New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
Deadline: May 7, 2027
Opportunity Number: PAR-25-279
Agency: National Institutes of Health
Open Date: November 25, 2024
Close Date: May 7, 2027
Status: Posted
CFDA Numbers: 93.396, 93.866, 93.865, 93.286
Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R01 Clinical Trial Required)
Deadline: January 7, 2028
Opportunity Number: PAR-25-289
Agency: National Institutes of Health
Open Date: November 25, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242
The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-292
Agency: National Institutes of Health
Open Date: November 25, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.866, 93.361, 93.393, 93.307, 93.399, 93.396, 93.279, 93.242
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
Deadline: November 17, 2026
Opportunity Number: PAR-25-158
Agency: National Institutes of Health
Open Date: November 25, 2024
Close Date: November 17, 2026
Status: Posted
CFDA Numbers: 93.273
Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-281
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242, 93.313
Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)
Deadline: December 23, 2027
Opportunity Number: RFA-HL-26-019
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: December 23, 2027
Status: Posted
CFDA Numbers: 93.837, 93.233, 93.839, 93.838
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-291
Agency: National Institutes of Health
Open Date: November 22, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.242